S&P 500 7,718.60 −0.38%
Nasdaq 26,506.99 −0.29%
S&P/TSX 36,513.80 −0.33%
Apple 319.97 −2.51%
Nvidia 230.36 +0.84%
Microsoft 499.70 −2.04%
Shopify 200.76 −0.10%
Royal Bank 291.48 −0.30%
CAD/USD 0.7233 −0.26%
CLOSED · 16:55 ET
Market ClerkRecap
Sun Sep 6 · markets closed2 signals today321 insider buys this week · $404MCIRO short report next: Sep 15The week ahead

PGEN

PRECIGEN, INC.
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
7.10
−0.04 −0.56%
USD · close Sep 4
MKT CAP $2.5BP/E DIV YIELD FCF YIELD -4.53%REV TTM NET INCOME −$157.7MNET DEBT $77.6M52W 3.10 – 7.44NEXT EARNINGS Nov 12SEC XBRL · TTM TO Invalid Date

Insider trading

SEC FORM 4 · OPEN-MARKET ONLY
−$2.3M
Net, 90 days
1 / 4
Buys / sells, 90 days
1
Distinct buyers
$25K
Bought, 90 days
TradedFiledInsiderTypeSharesPriceValue
Aug 26Aug 28KINDLER JEFFREY B · DirectorSell185,000$7.44$1.4M
Aug 25Aug 25Shah Rutul R · Chief Operating OfficerSell15,342$7.50$115K
Aug 25Aug 25Tennant Phil · Chief Commercial OfficerSell79,166$7.50$594K
Aug 21Aug 25Shah Rutul R · Chief Operating OfficerSell34,658$7.50$260K
Aug 21Aug 25AGEE NANCY H · DirectorBuy3,411$7.23$25K

Source: SEC EDGAR Form 4 filings, pulled nightly; open-market purchases and sales only, no option exercises or grants. The tracker, all tickers.

Watch PGEN. Know when insiders buy.
One email the day a filing lands. Free.